دورية أكاديمية
Gastrinomas and non-functioning pancreatic endocrine tumors in multiple endocrine neoplasia syndrome type-1 (MEN-1).
| العنوان: | Gastrinomas and non-functioning pancreatic endocrine tumors in multiple endocrine neoplasia syndrome type-1 (MEN-1). |
|---|---|
| المؤلفون: | Camera L; Department of Advanced Biomedical Sciences, Section of Radiology, University 'Federico II', Naples, Italy. camera@unina.it., Boccadifuoco F; Department of Advanced Biomedical Sciences, Section of Radiology, University 'Federico II', Naples, Italy., Modica R; Department of Endocrinology, University 'Federico II', Naples, Italy., Messerini L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Faggiano A; Department of Endocrinology, University 'La Sapienza', Rome, Italy., Romeo V; Department of Advanced Biomedical Sciences, Section of Radiology, University 'Federico II', Naples, Italy., Gaudieri V; Department of Advanced Biomedical Sciences, Section of Nuclear Medicine, University 'Federico II', Naples, Italy., Colao A; Department of Endocrinology, University 'Federico II', Naples, Italy., Maurea S; Department of Advanced Biomedical Sciences, Section of Radiology, University 'Federico II', Naples, Italy., Brunetti A; Department of Advanced Biomedical Sciences, Section of Radiology, University 'Federico II', Naples, Italy. |
| مؤلفون مشاركون: | European Neuroendocrine Tumor Society (ENETS) of Naples |
| المصدر: | Endocrine [Endocrine] 2023 Sep; Vol. 81 (3), pp. 459-463. Date of Electronic Publication: 2023 Apr 26. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Humana Press Country of Publication: United States NLM ID: 9434444 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-0100 (Electronic) Linking ISSN: 1355008X NLM ISO Abbreviation: Endocrine Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Feb. 1996- : Totowa, NJ : Humana Press Original Publication: Houndsmills, Basingstoke, Hants, UK : Macmillan Press, c1994- |
| مواضيع طبية MeSH: | Gastrinoma*/diagnostic imaging , Gastrinoma*/pathology , Pancreatic Neoplasms*/pathology , Multiple Endocrine Neoplasia Type 1*/complications , Multiple Endocrine Neoplasia Type 1*/pathology , Zollinger-Ellison Syndrome*/pathology, Humans |
| References: | S.S. Guo, M.P. Sawicki, Molecular and genetic mechanisms of tumorigenes in multiple endocrine neoplasia type-1. Mol. Endocrinol. 15, 1653–1664 (2001). (PMID: 10.1210/mend.15.10.071711579199) G. Effraimidis, U. Knigge, M. Rossing, P. Oturai, Å.K. Rasmussen, U. Feldt-Rasmussen, Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs). Semin. Cancer Biol. 79, 141–162 (2022). (PMID: 10.1016/j.semcancer.2021.04.01133905872) R.V. Thakker, P.J. Newey, G.V. Walls et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J. Clin. Endocrinol. Metab. 97, 2990–3011 (2012). (PMID: 10.1210/jc.2012-123022723327) B. Niederle, A. Selberherr, D.K. Bartsch et al. Multiple endocrine neoplasia type 1 and the pancreas: diagnosis and treatment of functioning and non-functioning pancreatic and duodenal neuroendocrine neoplasia within the MEN1 syndrome – an international consensus statement. Neuroendocrinology 111, 609–630 (2021). (PMID: 10.1159/00051179132971521) G.M. Doherty, Multiple endocrine neoplasia type 1: duodenopancreatic tumors. Surg. Oncol. 12, 135–143 (2003). (PMID: 10.1016/S0960-7404(03)00038-012946484) M.A. Kouvaraki, S.E. Shapiro, G.J. Cote et al. Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. World J. Surg. 30, 643–653 (2006). (PMID: 10.1007/s00268-006-0360-y16680581) M. Falconi, B. Eriksson, G. Kaltsas et al. ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology 103, 153–171 (2016). (PMID: 10.1159/00044317126742109) L. Camera, S. Paoletta, C. Mollica et al. Screening of pancreaticoduodenal endocrine tumours in patients with MEN 1: multidetector-row computed tomography vs. endoscopic ultrasound. Radio. Med. 116, 595–606 (2011). (PMID: 10.1007/s11547-011-0636-2) C. Barbe, A. Murat, B. Dupas et al. Magnetic resonance imaging versus endoscopic ultrasonography for the detection of pancreatic tumors in multiple endocrine neoplasia type-1. Dig. Liv Dis. 44, 228–234 (2012). (PMID: 10.1016/j.dld.2011.09.014) I.D. Nagtegaal, R.D. Odze, D. Klimstra et al. The 2019 WHO classification of tumours of the digestive system. Histopathology 76, 182–188 (2020). (PMID: 10.1111/his.1397531433515) C. Cappelli, U. Boggi, S. Mazzeo et al. Contrast enhancement pattern on multidetector CT predicts malignancy in pancreatic endocrine tumours. Eur. Radio. 25, 751–759 (2015). (PMID: 10.1007/s00330-014-3485-2) E. Belousova, G. Karmazanovsky, A. Kriger et al. Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades. Clin. Radio. 72, 150–158 (2017). (PMID: 10.1016/j.crad.2016.10.021) F. Salahshour, M.M. Mehrabinejad, A. Zare Dehnavi et al. Pancreatic neuroendocrine tumors (pNETs): the predictive value of MDCT characteristics in the differentiation of histopathological grades. Abdom. Radio. 45, 3155–3162 (2020). (PMID: 10.1007/s00261-019-02372-x) S. Chiloiro, F. Lanza, A. Bianchi, G. et al. Pancreatic neuroendocrine tumors in MEN-1 disease: a monocentric longitudinal and prognostic study. Endocrine 60, 362–367 (2018). https://doi.org/10.1007/S12020-017-1327-0. V. Ramundo, M. Del Prete, V. Marotta et al. Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours. Clin. Endocrinol. 80, 850–855 (2014). (PMID: 10.1111/cen.12411) A. Faggiano, R. Modica, F. Lo Calzo et al. Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors < 2 centimeters. J. Clin. Endocrinol. Metab. 105, dgz007 (2020). https://doi.org/10.1210/clinem/dgz007. S. Lastoria, F. Marciello, A. Faggiano et al. Role of 68 Ga-DOTATATE PET/CT in patients with multiple nedocrine neoplasia type 1 (MEN1). Endocrine 52, 488–494 (2016). https://doi.org/10.1007/s12020-015-0702y. N. Lévy-Bohbot, C. Merle, P. Goudet et al. Prevalence, characteristics and prognosis of MEN 1-associated glucagonomas, VIPomas, and somatostatinomas: study from the GTE (Groupe des Tumeurs Endocrines) registry. Gastroenterol. Clin. Biol. 28, 1075–1081 (2004). (PMID: 10.1016/S0399-8320(04)95184-615657529) F. Tonelli, G. Fratini, G. Nesi et al. Pancreatectomy in multiple endocrine neoplasia type-1 related gastrinomas and pancreatic endocrine neoplasia. Ann. Surg. 244, 61–70 (2006). (PMID: 10.1097/01.sla.0000218073.77254.62167943901570585) R. Casadei, C. Ricci, G. Taffurelli et al. Is total pancreatectomy as feasible, safe, efficacious and cost-effective as pancreaticoduodenectomy? A single center, prospective, observational study. J. Gastrointest. Surg. 20, 1595–1607 (2016). https://doi.org/10.1007/s11605-016-3201-4. |
| SCR Disease Name: | Non functioning pancreatic endocrine tumor |
| تواريخ الأحداث: | Date Created: 20230426 Date Completed: 20230807 Latest Revision: 20231010 |
| رمز التحديث: | 20240628 |
| DOI: | 10.1007/s12020-023-03373-z |
| PMID: | 37099246 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1559-0100 |
|---|---|
| DOI: | 10.1007/s12020-023-03373-z |